Ru Yang

Director/Board Member at SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD

40 year

Technology Services

Consumer Services

Health Services

Profile

Ru Yang is currently working as an Independent Director at Xiamen Zeesan Biotech Co., Ltd.
and Shenzhen Kingsun Science & Technology Co., Ltd.
Prior to this, Ms. Yang graduated from Southwest University of Political & Law in 2009.

Ru Yang active positions

Companies	Position	Start
SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD	Director/Board Member	2021-07-31
Xiamen Zeesan Biotech Co., Ltd. Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China.	Director/Board Member	2021-08-22

All active positions of Ru Yang

Training of Ru Yang

Southwest University of Political & Law

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ru Yang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD	Technology Services

Private companies	1
Xiamen Zeesan Biotech Co., Ltd. Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China.	Health Services